Karolinska Development's portfolio company Umecrine Cognition initiates second part of clinical phase 1a/2 study in PBC marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
STOCKHOLM – 26 April 2024. Karolinska Development AB today publishes its Interim Report - January-March 2024. The full report is available on the Company s website. “2024 has begun strongly with.
STOCKHOLM – 16 February 2024. Karolinska Development AB today publishes its Year-end Report - January-December 2023. The full report is available on the Company s website. “2023 has been a year.
Hepatic Encephalopathy Market Size, Share, Revenue, Trends And Drivers For 2024-2033 einnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from einnews.com Daily Mail and Mail on Sunday newspapers.
Karolinska Development's portfolio company Umecrine Cognition presents positive effects of golexanolone in a preclinical model of cholestasis streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.